AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $226,000 | -7.8% | 6,760 | -4.4% | 0.00% | 0.0% |
| Q4 2021 | $245,000 | +10.4% | 7,069 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $222,000 | -11.6% | 7,133 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $251,000 | -15.2% | 6,904 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $296,000 | -9.8% | 6,770 | -5.4% | 0.00% | 0.0% |
| Q4 2020 | $328,000 | +39.6% | 7,158 | +0.8% | 0.00% | 0.0% |
| Q3 2020 | $235,000 | +9.8% | 7,100 | -2.8% | 0.00% | 0.0% |
| Q2 2020 | $214,000 | +5.4% | 7,307 | -3.3% | 0.00% | 0.0% |
| Q1 2020 | $203,000 | -30.7% | 7,559 | -13.3% | 0.00% | 0.0% |
| Q4 2019 | $293,000 | -19.7% | 8,723 | -10.7% | 0.00% | -50.0% |
| Q3 2019 | $365,000 | -19.6% | 9,766 | -6.2% | 0.00% | 0.0% |
| Q2 2019 | $454,000 | 0.0% | 10,414 | -2.3% | 0.00% | 0.0% |
| Q1 2019 | $454,000 | -10.1% | 10,657 | -5.5% | 0.00% | -33.3% |
| Q4 2018 | $505,000 | -34.9% | 11,278 | -0.5% | 0.00% | -25.0% |
| Q3 2018 | $776,000 | – | 11,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 3,087,229 | $96,322,000 | 4.36% |
| RGM Capital, LLC | 2,521,930 | $78,684,000 | 3.86% |
| Tributary Capital Management, LLC | 322,946 | $10,076,000 | 0.78% |
| Alpha Paradigm Partners, LLC | 52,844 | $1,649,000,000 | 0.66% |
| HEARTLAND ADVISORS INC | 307,416 | $9,591,000 | 0.58% |
| Factorial Partners, LLC | 23,400 | $730,000 | 0.50% |
| Champlain Investment Partners, LLC | 2,082,903 | $64,987,000 | 0.31% |
| WESTWOOD HOLDINGS GROUP INC | 741,503 | $23,135,000 | 0.25% |
| Campbell & CO Investment Adviser LLC | 22,100 | $690,000 | 0.22% |
| AIGEN INVESTMENT MANAGEMENT, LP | 26,488 | $826,000 | 0.16% |